name,category,terms6-pyruvoyltetrahydropterin synthase,INTERPRO[450006489$IPR007115:6-pyruvoyl tetrahydropterin synthase-related, 450006490$IPR007116:6-pyruvoyl tetrahydropterin synthase]
6-pyruvoyltetrahydropterin synthase,KEGG_PATHWAY[470038800$hsa00790:Folate biosynthesis]
6-pyruvoyltetrahydropterin synthase,OMIM_DISEASE[520002461$Hyperphenylalaninemia due to PTS deficiency, 520002462$Hyperphenylalaninemia, BH4-deficient, A, 520003975$Phenylketonuria due to PTS deficiency]
6-pyruvoyltetrahydropterin synthase,PIR_SUPERFAMILY[630006041$PIRSF006113:6-pyruvoyl tetrahydropterin synthase]
6-pyruvoyltetrahydropterin synthase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000446$disease mutation, 790000891$lyase, 790000937$metal-binding, 790001141$phenylketonuria, 790001162$phosphoprotein, 790001497$tetrahydrobiopterin biosynthesis, 790001648$zinc]
6-pyruvoyltetrahydropterin synthase,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850000114$active site:Proton acceptor, 850002525$chain:6-pyruvoyl tetrahydrobiopterin synthase, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
B-cell CLL/lymphoma 7A,INTERPRO[450006210$IPR006804:BCL7, N-terminal]
B-cell CLL/lymphoma 7A,OMIM_DISEASE[520000500$B-cell non-Hodgkin lymphoma, high-grade]
B-cell CLL/lymphoma 7A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
B-cell CLL/lymphoma 7A,UP_SEQ_FEATURE[850007046$chain:B-cell CLL/lymphoma 7 protein family member A, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
MORN repeat containing 3,COG_ONTOLOGY[90000070$Function unknown]
MORN repeat containing 3,INTERPRO[450002977$IPR003409:MORN motif]
MORN repeat containing 3,SMART[760000606$SM00698:MORN]
MORN repeat containing 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001304$repeat]
MORN repeat containing 3,UP_SEQ_FEATURE[850032493$chain:MORN repeat-containing protein 3, 850116382$repeat:MORN 1, 850116384$repeat:MORN 2, 850116385$repeat:MORN 3, 850116386$repeat:MORN 4, 850116387$repeat:MORN 5, 850116388$repeat:MORN 6, 850116389$repeat:MORN 7, 850118574$splice variant]
N-acetylated alpha-linked acidic dipeptidase-like 1,INTERPRO[450002761$IPR003137:Protease-associated PA, 450006727$IPR007365:Transferrin receptor-like, dimerisation, 450006838$IPR007484:Peptidase M28]
N-acetylated alpha-linked acidic dipeptidase-like 1,PIR_SUPERFAMILY[630002664$PIRSF002548:transferrin receptor]
N-acetylated alpha-linked acidic dipeptidase-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000242$carboxypeptidase, 790000264$cell membrane, 790000356$complete proteome, 790000438$dipeptidase, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790000937$metal-binding, 790000941$metalloprotease, 790000993$multifunctional enzyme, 790001212$polymorphism, 790001252$Protease, 790001409$Signal-anchor, 790001555$transmembrane, 790001648$zinc]
N-acetylated alpha-linked acidic dipeptidase-like 1,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850000096$active site:Nucleophile; for NAALADase activity, 850033172$chain:N-acetylated-alpha-linked acidic dipeptidase-like protein, 850105770$glycosylation site:N-linked (GlcNAc...), 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850113538$region of interest:NAALADase, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
PCTAIRE protein kinase 3,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450009944$IPR010916:TonB box, conserved site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
PCTAIRE protein kinase 3,SMART[760000193$SM00220:S_TKc]
PCTAIRE protein kinase 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase]
PCTAIRE protein kinase 3,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010438$chain:Cell division protein kinase 18, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7,INTERPRO[450000135$IPR000159:Ras-association]
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7,SMART[760000284$SM00314:RA]
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7,UP_SEQ_FEATURE[850056680$chain:Ras association domain-containing protein 7, 850102586$compositionally biased region:Pro-rich, 850105145$domain:Ras-associating, 850117295$sequence variant, 850118574$splice variant]
SMAD family member 6,BIOCARTA[30000015$h_alkPathway:ALK in cardiac myocytes]
SMAD family member 6,INTERPRO[450000993$IPR001132:SMAD domain, Dwarfin-type, 450003179$IPR003619:MAD homology 1, Dwarfin-type, 450011686$IPR013019:MAD homology, MH1, 450012402$IPR013790:Dwarfin, 450016174$IPR017855:SMAD domain-like]
SMAD family member 6,KEGG_PATHWAY[470038850$hsa04350:TGF-beta signaling pathway]
SMAD family member 6,PIR_SUPERFAMILY[630028833$PIRSF037286:Smad protein, 630030640$PIRSF500412:inhibitory Smad protein, Smad 6/Smad 7 types]
SMAD family member 6,SMART[760000463$SM00523:DWA, 760000464$SM00524:DWB]
SMAD family member 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
SMAD family member 6,UP_SEQ_FEATURE[850032508$chain:Mothers against decapentaplegic homolog 6, 850102565$compositionally biased region:Poly-Ala, 850102566$compositionally biased region:Poly-Arg, 850102573$compositionally biased region:Poly-Gly, 850102576$compositionally biased region:Poly-Leu, 850102580$compositionally biased region:Poly-Pro, 850104765$domain:MH1, 850104766$domain:MH2, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,BIOCARTA[30000314$h_WNVpathway:West Nile Virus]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,COG_ONTOLOGY[90000073$General function prediction only]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,SMART[760000328$SM00360:RRM]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000109$Apoptosis, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,UP_SEQ_FEATURE[850035207$chain:Nucleolysin TIAR, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
acyl-Coenzyme A dehydrogenase, short/branched chain,COG_ONTOLOGY[90000084$Lipid metabolism]
acyl-Coenzyme A dehydrogenase, short/branched chain,INTERPRO[450005523$IPR006089:Acyl-CoA dehydrogenase, conserved site, 450005524$IPR006090:Acyl-CoA oxidase/dehydrogenase, type 1, 450005525$IPR006091:Acyl-CoA oxidase/dehydrogenase, central region, 450005526$IPR006092:Acyl-CoA dehydrogenase, N-terminal, 450012383$IPR013764:Acyl-CoA oxidase/dehydrogenase, type1/2, C-terminal, 450012398$IPR013786:Acyl-CoA dehydrogenase/oxidase, N-terminal]
acyl-Coenzyme A dehydrogenase, short/branched chain,KEGG_PATHWAY[470038734$hsa00071:Fatty acid metabolism, 470038748$hsa00280:Valine, leucine and isoleucine degradation]
acyl-Coenzyme A dehydrogenase, short/branched chain,OMIM_DISEASE[520000005$2-methylbutyrylglycinuria]
acyl-Coenzyme A dehydrogenase, short/branched chain,PIR_SUPERFAMILY[630000218$PIRSF000182:acyl-CoA dehydrogenase]
acyl-Coenzyme A dehydrogenase, short/branched chain,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000446$disease mutation, 790000537$FAD, 790000543$fatty acid metabolism, 790000559$Flavoprotein, 790000873$lipid metabolism, 790000969$mitochondrion, 790001092$oxidoreductase, 790001212$polymorphism, 790001550$transit peptide]
acyl-Coenzyme A dehydrogenase, short/branched chain,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000342$binding site:FAD; shared with dimeric partner, 850000555$binding site:Substrate, 850000574$binding site:Substrate; via amide nitrogen, 850000576$binding site:Substrate; via carbonyl oxygen, 850060670$chain:Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial, 850105852$helix, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850106291$nucleotide phosphate-binding region:FAD; shared with dimeric partner, 850114716$region of interest:Substrate binding, 850117295$sequence variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
calmodulin binding transcription activator 1,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region, 450001870$IPR002110:Ankyrin, 450002569$IPR002909:Cell surface receptor IPT/TIG, 450005011$IPR005559:CG-1]
calmodulin binding transcription activator 1,SMART[760000009$SM00015:IQ, 760000220$SM00248:ANK, 760000375$SM00429:IPT]
calmodulin binding transcription activator 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
calmodulin binding transcription activator 1,UP_SEQ_FEATURE[850009135$chain:Calmodulin-binding transcription activator 1, 850102573$compositionally biased region:Poly-Gly, 850102585$compositionally biased region:Poly-Val, 850102903$DNA-binding region:CG-1, 850104420$domain:IPT/TIG, 850104440$domain:IQ 1, 850104451$domain:IQ 2, 850104462$domain:IQ 3, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand]
ets variant 3,BIOCARTA[30000108$h_etsPathway:METS affect on Macrophage Differentiation]
ets variant 3,INTERPRO[450000358$IPR000418:Ets, 450010816$IPR011991:Winged helix repressor DNA-binding]
ets variant 3,OMIM_DISEASE[520001144$Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study]
ets variant 3,SMART[760000360$SM00413:ETS]
ets variant 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
ets variant 3,UP_SEQ_FEATURE[850018043$chain:ETS translocation variant 3, 850102913$DNA-binding region:ETS, 850106258$modified residue, 850118574$splice variant]
family with sequence similarity 134, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001020$neuropathy, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
family with sequence similarity 134, member B,UP_SEQ_FEATURE[850045871$chain:Protein FAM134B, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
feline leukemia virus subgroup C cellular receptor family, member 2,INTERPRO[450010529$IPR011701:Major facilitator superfamily MFS-1]
feline leukemia virus subgroup C cellular receptor family, member 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
feline leukemia virus subgroup C cellular receptor family, member 2,UP_SEQ_FEATURE[850019160$chain:Feline leukemia virus subgroup C receptor-related protein 2, 850102572$compositionally biased region:Poly-Glu, 850110728$region of interest:8 X 6 AA tandem repeats of P-S-[VS]-S- [VIAG]-[HNP], 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115551$repeat:6; approximate, 850115567$repeat:7; approximate, 850115571$repeat:8, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
hydroxyacid oxidase 2 (long chain),INTERPRO[450000227$IPR000262:FMN-dependent dehydrogenase, 450007554$IPR008259:FMN-dependent alpha-hydroxy acid dehydrogenase, active site, 450010916$IPR012133:Alpha-hydroxy acid dehydrogenase, FMN-dependent, 450012397$IPR013785:Aldolase-type TIM barrel, 450016247$IPR017934:FMN-dependent alpha-hydroxy acid dehydrogenase]
hydroxyacid oxidase 2 (long chain),KEGG_PATHWAY[470038788$hsa00630:Glyoxylate and dicarboxylate metabolism]
hydroxyacid oxidase 2 (long chain),PIR_SUPERFAMILY[630000160$PIRSF000138:Al-hdrx_acd_dh, 630000161$PIRSF000138:alpha-hydroxy acid dehydrogenase, FMN-dependent]
hydroxyacid oxidase 2 (long chain),SP_PIR_KEYWORDS[790000356$complete proteome, 790000559$Flavoprotein, 790000562$fmn, 790001092$oxidoreductase, 790001128$peroxisome, 790001212$polymorphism]
hydroxyacid oxidase 2 (long chain),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000355$binding site:FMN, 850000555$binding site:Substrate, 850025230$chain:Hydroxyacid oxidase 2, 850104008$domain:FMN hydroxy acid dehydrogenase, 850106292$nucleotide phosphate-binding region:FMN, 850117294$sequence conflict, 850117295$sequence variant, 850117578$short sequence motif:Microbody targeting signal]
mitogen-activated protein kinase 7,BBID[10000003$100.MAPK_signaling_cascades]
mitogen-activated protein kinase 7,BIOCARTA[30000104$h_erk5Pathway:Role of Erk5 in Neuronal Survival, 30000135$h_hdacPathway:Control of skeletal myogenesis by HDAC & calcium/calmodulin-dependent kinase (CaMK), 30000180$h_mapkPathway:MAPKinase Signaling Pathway]
mitogen-activated protein kinase 7,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450003094$IPR003527:MAP kinase, conserved site, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
mitogen-activated protein kinase 7,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038858$hsa04540:Gap junction, 470038877$hsa04722:Neurotrophin signaling pathway, 470038883$hsa04912:GnRH signaling pathway]
mitogen-activated protein kinase 7,SMART[760000193$SM00220:S_TKc]
mitogen-activated protein kinase 7,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000258$cell cycle, 790000356$complete proteome, 790000407$cytoplasm, 790000434$differentiation, 790000445$direct protein sequencing, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
mitogen-activated protein kinase 7,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850032083$chain:Mitogen-activated protein kinase 7, 850102404$compositionally biased region:Arg-rich, 850102565$compositionally biased region:Poly-Ala, 850102586$compositionally biased region:Pro-rich, 850105086$domain:Protein kinase, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850113339$region of interest:May not be required for kinase activity; required to stimulate MEF2C activity, 850113683$region of interest:Necessary for oligomerization, 850113810$region of interest:Nuclear localization signal, 850114257$region of interest:Required for binding to MAP2K5, 850114282$region of interest:Required for cytoplasmic targeting, 850117294$sequence conflict, 850117295$sequence variant, 850117751$short sequence motif:TXY, 850118574$splice variant]
ornithine aminotransferase (gyrate atrophy),BIOCARTA[30000025$h_argininecPathway:Catabolic Pathways for Arginine , Histidine, Glutamate, Glutamine, and Proline]
ornithine aminotransferase (gyrate atrophy),INTERPRO[450005262$IPR005814:Aminotransferase class-III, 450009240$IPR010164:Ornithine aminotransferase, 450013864$IPR015421:Pyridoxal phosphate-dependent transferase, major region, subdomain 1]
ornithine aminotransferase (gyrate atrophy),KEGG_PATHWAY[470038752$hsa00330:Arginine and proline metabolism]
ornithine aminotransferase (gyrate atrophy),OMIM_DISEASE[520002204$Gyrate atrophy of choroid and retina with ornithinemia, B6 responsive or unresponsive]
ornithine aminotransferase (gyrate atrophy),PIR_SUPERFAMILY[630000619$PIRSF000519:ornithine-oxo-acid aminotransferase]
ornithine aminotransferase (gyrate atrophy),SP_PIR_KEYWORDS[790000002$3d-structure, 790000070$Aminotransferase, 790000116$arginine catabolism, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000967$mitochondrial matrix, 790000969$mitochondrion, 790001162$phosphoprotein, 790001212$polymorphism, 790001283$pyridoxal phosphate, 790001547$transferase, 790001550$transit peptide]
ornithine aminotransferase (gyrate atrophy),UP_SEQ_FEATURE[850036219$chain:Ornithine aminotransferase, hepatic form, 850036221$chain:Ornithine aminotransferase, renal form, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand, 850118618$transit peptide:Mitochondrion; in hepatic form, 850118619$transit peptide:Mitochondrion; in renal form, 850118624$turn]
zinc finger, DHHC-type containing 18,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger, DHHC-type containing 18,INTERPRO[450001416$IPR001594:Zinc finger, DHHC-type]
zinc finger, DHHC-type containing 18,PIR_SUPERFAMILY[630029026$PIRSF037457:palmitoyltransferase, ZDHHC9 type]
zinc finger, DHHC-type containing 18,SP_PIR_KEYWORDS[790000025$Acyltransferase, 790000356$complete proteome, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001547$transferase, 790001555$transmembrane, 790001648$zinc, 790001651$zinc-finger]
zinc finger, DHHC-type containing 18,UP_SEQ_FEATURE[850000145$active site:S-palmitoyl cysteine intermediate, 850036755$chain:Palmitoyltransferase ZDHHC18, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850118623$transmembrane region, 850118801$zinc finger region:DHHC-type]
